Endlyz Therapeutics

Endlyz Therapeutics is developing disease-modifying therapeutics to restore endo-lysosomal function and halt neurodegeneration in Parkinson’s disease and other dementias

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

Endlyz Therapeutics is developing disease-modifying therapeutics to restore endo-lysosomal function and halt neurodegeneration in Parkinson’s disease and other dementias.

02Backed By1 investor

OSOxford Science Enterprises→

03Similar Companies